Stockholders' Deficit (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions		3 Months Ended				6 Months Ended		9 Months Ended
	May 07, 2019	Sep. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Mar. 31, 2018	Jun. 30, 2019	Jun. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018	Dec. 31, 2017
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total liabilities and total stockholders’ (deficit) equity		$ (2,223)	$ (2,423)	$ (2,619)	$ (2,196)		$ (2,268)	$ (2,223)	$ (2,619)	$ (2,463)	$ (2,027)
Net proceeds of common stock in connection with stock options and RSUs		1	2	3	15	$ 2	(2)
Net proceeds from the sale of SciPlay common stock								342
Gain (Loss) on Disposition of Stock in Subsidiary						419
Stock-based compensation		9	11	9	7	10	15
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest		18		(352)		(75)		(81)	(559)
Net Income (Loss) Attributable to Parent		14	(24)	(352)	(202)	(77)	(6)	(87)	(559)
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest		4		0		2		6	0
Net Income (Loss) Attributable to Noncontrolling Interest		4						6
Other comprehensive loss		(35)	51	(5)	52	(51)	(83)		(37)
Common Stock, Value, Outstanding		1				1		1		1
Additional Paid in Capital, Common Stock		1,197				1,187		1,197		835
Retained Earnings (Accumulated Deficit)		(2,911)				(2,925)		(2,911)		(2,824)
Treasury Stock, Value		175				175		175		175
Accumulated Other Comprehensive Income (Loss), Net of Tax		(335)				(300)		(335)		(300)
Stockholders' Equity Attributable to Noncontrolling Interest		98				94		98		0
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		(2,125)				(2,118)		(2,125)		(2,463)
Share-based compensation expense		9		10				33	34
Related to SGC stock options
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense		1		3				4	11
Related to SGC RSUs
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense		6		7				23	23
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total liabilities and total stockholders’ (deficit) equity			1	1	1		1		1	1	1
Additional Paid in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total liabilities and total stockholders’ (deficit) equity			848	823	800		817		823	835	808
Net proceeds of common stock in connection with stock options and RSUs		1	2	(3)	(15)	2	2
Stock-based compensation		9	11	9	7	9	15
Accumulated Loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total liabilities and total stockholders’ (deficit) equity			(2,848)	(3,032)	(2,674)		(2,680)		(3,032)	(2,824)	(2,461)
Net Income (Loss) Attributable to Parent			(24)	(352)	(202)		(6)
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets											(11)
Treasury Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total liabilities and total stockholders’ (deficit) equity			(175)	(175)	(175)		(175)		(175)	(175)	(175)
Accumulated Other Comprehensive Loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total liabilities and total stockholders’ (deficit) equity			(249)	(236)	(148)		(231)		(236)	(300)	(200)
Other comprehensive loss		(35)	51	(5)	$ 52	(51)	$ (83)
Noncontrolling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation						1
Stockholders' Equity Attributable to Noncontrolling Interest			$ 0							$ 0
Accounting Standards Update 2014-09 [Member] | Accumulated Loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets											$ (11)
SciPlay | Related to SGC RSUs
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense		$ 2		$ 0				$ 6	$ 0
IPO [Member] | Additional Paid in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net proceeds from the sale of SciPlay common stock	$ 312					328
IPO [Member] | Noncontrolling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net proceeds from the sale of SciPlay common stock	$ 30					$ 91
SciPlay Corporation Long-Term Incentive Plan [Member] [Domain] | Common Class A [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized		6.5						6.5
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number		4.0						4.0
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price		$ 15.30						$ 15.30